Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03910296 · ClinicalTrials.gov registry record
Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 10
- Enrollment target
NCT03910296 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 10 participants.
The verdict
NCT03910296 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to develop a psychological treatment for patients with cancer, focused on the psychological symptoms they experience during opioid therapy.
Interventions
- BEHAVIORAL Acceptance & Commitment Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-02-20 |
| Est. Completion | 2021-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03910296
The ClinicalTrials.gov registry entry for NCT03910296 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acceptance & Commitment Therapy is the first listed.
NCT03910296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03910296 about?
NCT03910296 is a clinical study titled "Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain". The purpose of this research study is to develop a psychological treatment for patients with cancer, focused on the psychological symptoms they experience during opioid therapy.
What is the current status of trial NCT03910296?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-02-20. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT03910296?
The interventions under investigation include: Acceptance & Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03910296?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.